NCT07524231 Evaluation of the Effects of Laughter Yoga
| NCT ID | NCT07524231 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Firat University |
| Condition | Multiple Sclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2026-03-10 |
| Primary Completion | 2026-07-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2026-03-10 with a primary completion date of 2026-07-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled study aims to evaluate the effects of laughter yoga on pain intensity, fatigue, and beta-endorphin levels in patients with Multiple Sclerosis. Laughter yoga, a complementary therapy combining breathing exercises and laughter techniques, may help improve symptom management and psychological well-being in individuals with MS.
Eligibility Criteria
Inclusion Criteria: * • Being over 18 years old * Being able to communicate adequately * Volunteering to participate in the research Exclusion Criteria: * Unwillingness to participate in the study Having severe cognitive impairment that prevents understanding or participation in the intervention Having a psychiatric disorder that may affect participation in the study Experiencing an acute MS relapse during the study period Having another serious neurological or chronic disease that may affect the study outcomes Regular participation in another complementary therapy program similar to laughter yoga Communication problems that prevent participation in the intervention sessions
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07524231 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07524231 currently recruiting?
Yes, NCT07524231 is actively recruiting participants. Contact the research team at gulkaya@firat.edu.tr for enrollment information.
Where is the NCT07524231 trial being conducted?
This trial is being conducted at Elâzığ, Turkey (Türkiye).
Who is sponsoring the NCT07524231 clinical trial?
NCT07524231 is sponsored by Firat University. The trial plans to enroll 72 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.